Article info
PDFReview
Suicide risk with selective serotonin reuptake inhibitors and other new-generation antidepressants in adults: a systematic review and meta-analysis of observational studies
- Correspondence to Michael P Hengartner, Department of Applied Psychology, Zurcher Hochschule fur Angewandte Wissenschaften, Zurich CH-8005, Switzerland; michaelpascal.hengartner{at}zhaw.ch
Citation
Suicide risk with selective serotonin reuptake inhibitors and other new-generation antidepressants in adults: a systematic review and meta-analysis of observational studies
Publication history
- Received May 22, 2020
- Revised November 25, 2020
- Accepted February 20, 2021
- First published March 8, 2021.
Online issue publication
May 10, 2021
Article Versions
- Previous version (8 March 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.